Debt / revenue moved 460 bp lower
Debt / revenue changed -460 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
321.91%→317.31%2 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →FTV financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow / net income decreased 39.3%
Operating cash flow / net income changed -39.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.99→1.822 prior comparisons
Revenue increased 7.8%
Revenue changed +7.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$1.0B→$1.1B2 prior comparisons
Gross margin moved 96 bp higher
Gross margin changed +96 basis points from the comparable as-filed period.
63.21%→64.16%2 prior comparisons
Debt / equity moved 825 bp higher
Debt / equity changed +825 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
50.84%→59.09%4 prior comparisons
Free-cash-flow margin moved 1239 bp higher
Free-cash-flow margin changed +1239 basis points from the comparable as-filed period.
13.22%→25.62%2 prior comparisons
Operating cash-flow margin moved 1227 bp higher
Operating cash-flow margin changed +1227 basis points from the comparable as-filed period.
16.01%→28.28%2 prior comparisons
Stock-based compensation decreased 58.9%
Stock-based compensation changed -58.9% from the comparable as-filed period.
$50.9M→$20.9M2 prior comparisons
Inventory / revenue moved 178 bp lower
Inventory / revenue changed -178 basis points from the comparable as-filed period.
30.24%→28.46%2 prior comparisons
Debt / assets moved 274 bp higher
Debt / assets changed +274 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
27.82%→30.55%4 prior comparisons
Working capital / assets moved 873 bp higher
Working capital / assets changed +873 basis points from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
-6.21%→2.53%4 prior comparisons
Cash / debt moved 229 bp lower
Cash / debt changed -229 basis points from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
13.03%→10.74%4 prior comparisons
Cash & equivalents decreased 12.4%
Cash & equivalents changed -12.4% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$430.8M→$377.3M4 prior comparisons
Current assets decreased 8.9%
Current assets changed -8.9% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
$1.7B→$1.6B4 prior comparisons
Gross debt increased 6.3%
Gross debt changed +6.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$3.3B→$3.5B4 prior comparisons
Reported total debt increased 6.3%
Reported total debt changed +6.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. This reverses 2 consecutive comparable moves in the opposite direction.
$3.3B→$3.5B4 prior comparisons
Stockholders' equity decreased 8.6%
Stockholders' equity changed -8.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$6.5B→$5.9B4 prior comparisons
Gross profit increased 9.5%
Gross profit changed +9.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$649.2M→$710.6M2 prior comparisons
Shares outstanding decreased 6.3%
Shares outstanding changed -6.3% from the comparable as-filed period. The change ranks at the 50th percentile of 8 prior comparable changes.
317,611,636→297,644,4568 prior comparisons
Research & development increased 10.0%
Research & development changed +10.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$62.0M→$68.2M2 prior comparisons
Net debt increased 9.1%
Net debt changed +9.1% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$2.9B→$3.1B4 prior comparisons
Working capital changed across a sign change
Working capital changed +139.4% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes. Relative percentage is de-emphasized because the comparison has a sign change.
-$737.9M→$290.7M4 prior comparisons
Trade receivables increased 5.7%
Trade receivables changed +5.7% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 4 consecutive comparable moves in the opposite direction.
$633.6M→$669.5M4 prior comparisons
Capex / revenue moved 12 bp lower
Capex / revenue changed -12 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
2.78%→2.66%2 prior comparisons
Total assets decreased 3.2%
Total assets changed -3.2% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$11.9B→$11.5B4 prior comparisons
Receivables / revenue moved 124 bp lower
Receivables / revenue changed -124 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
61.69%→60.45%2 prior comparisons
Cost of revenue increased 5.0%
Cost of revenue changed +5.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$377.9M→$396.9M2 prior comparisons
Selling, general & administrative decreased 4.9%
Selling, general & administrative changed -4.9% from the comparable as-filed period.
$427.6M→$406.5M2 prior comparisons
Capital expenditure increased 3.1%
Capital expenditure changed +3.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
$28.6M→$29.5M3 prior comparisons
Inventory increased 1.5%
Inventory changed +1.5% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes. This reverses 3 consecutive comparable moves in the opposite direction.
$310.6M→$315.2M4 prior comparisons
R&D / revenue moved 12 bp higher
R&D / revenue changed +12 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
6.04%→6.16%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.